Zoetis inc stock.

Nov 24, 2023 · Analyzing ZTS Stock Performance. On Wednesday, Zoetis Inc [NYSE: ZTS] rose 0.35% to $179.35. The stock’s lowest price that day was $178.775, but it reached a high of $180.97 in the same session. During the last five days, there has been a surge of approximately 2.71%. Over the course of the year, Zoetis Inc shares have jumped approximately 22 ...

Zoetis inc stock. Things To Know About Zoetis inc stock.

Analyst Forecast. According to 6 analysts, the average rating for ZTS stock is "Strong Buy." The 12-month stock price forecast is $223.0, which is an increase of 24.27% from the latest price.Information News Events & Presentations Stock Information Financials Governance Contact Zoetis.com Stock Quote Price 175.79 Volume 14 Change -1.18 % Change -0.67% Today's Open 177.87 Previous Close 176.97 Intraday High 178.06 Intraday Low 175.24 52 Week High 194.99 52 Week Low 140.76 Pricing delayed by 20 minutes. Last Updated 11/29/2023 4:00 PMThe surge in investment and spending in global medicine is fueling the pharma industry. Therefore, investors could consider investing in quality pharma stocks Zoetis Inc. (ZTS), Wave Life Sciences Ltd. (WVE), and Johnson & Johnson (JNJ).The IQVIA Institute for Human Data Science predicts a surge in global medication spending, …PARSIPPANY, N.J.--(BUSINESS WIRE)-- The Board of Directors of Zoetis Inc. (NYSE:ZTS) has declared a dividend of $0.375 per share for the second quarter of 2023. The dividend will be paid on Thursday, June 1, 2023, to all holders of record of the Company’s common stock as of the close of business on Friday, April 21, 2023.

Zoetis Inc (ZTS) stock is up 1.56% while the S&P 500 is lower by -0.73% as of 3:06 PM on Monday, Dec 4. ZTS is up $2.79 from the previous closing price of $179.13 on volume of 907,604 shares. Over the past year the S&P 500 is up 14.06% while ZTS is up 17.12%. ZTS earned $4.92 a per share in the over the last 12 months, giving it a price-to ...Zoetis Inc (ZTS) stock is up 1.56% while the S&P 500 is lower by -0.73% as of 3:06 PM on Monday, Dec 4. ZTS is up $2.79 from the previous closing price of $179.13 on volume of 907,604 shares. Over the past year the S&P 500 is up 14.06% while ZTS is up 17.12%. ZTS earned $4.92 a per share in the over the last 12 months, giving it a price-to ...Vanessa Broadhurst ZTS stock SEC Form 4 insiders trading. Vanessa has made over 3 trades of the Zoetis Inc stock since 2022, according to the Form 4 filled with the SEC. Most recently Vanessa exercised 1,592 units of ZTS stock worth $272,670 on 10 February 2023.. The largest trade Vanessa's ever made was exercising 2,557 units of …

Dec 4, 2023 · Read Our Latest Research Report on Zoetis. Zoetis Stock Up 1.6 %. NYSE ZTS traded up $2.91 during midday trading on Monday, hitting $182.04. 584,069 shares of the company traded hands, compared to ...

Nicholas Ashton ZTS stock SEC Form 4 insiders trading. Nicholas has made over 1 trades of the Zoetis Inc stock since 2023, according to the Form 4 filled with the SEC. Most recently Nicholas exercised 492 units of ZTS stock worth $87,965 on 30 October 2023.. The largest trade Nicholas's ever made was exercising 492 units of Zoetis Inc …PARSIPPANY, N.J.--(BUSINESS WIRE)-- Zoetis Inc. (NYSE:ZTS) today announced the completion of its acquisition of Basepaws, a privately held petcare genetics company, which provides pet owners with genetic tests, analytics and early health risk assessments. The genetic insights from Basepaws help pet owners and veterinarians …ZTS - Zoetis Inc - Stock screener for investors and traders, financial visualizations. 74.38 -1.58(-2.08%) Gold 2,091.70 +34.50(+1.68%) Advertisement Zoetis Inc. (ZTS) NYSE - NYSE Delayed Price. Currency in USD Follow 2W 10W 9M 179.13 +2.46 (+1.39%) At close: 04:00PM EST 180.00...

13 abr 2023 ... Zoetis Inc. (ZTS) develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States ...

The estimated Net Worth of Robert W Scully is at least $6.6 million dollars as of 19 February 2021. Mr. Scully owns over 7,590 units of Zoetis Inc stock worth over $1,456,901 and over the last 13 years he sold ZTS stock worth over $4,789,296. In addition, he makes $355,000 as Independent Director at Zoetis Inc.

Get the latest Chewy Inc (CHWY) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.Transcript : Zoetis Inc. Presents at Piper Sandler 35th Annual Healthcare Conference, Nov-28-2023 01:00 PM. CI. Nov. 21. Zoetis Insider Sold Shares Worth …Stocks trading online may seem like a great way to make money, but if you want to walk away with a profit rather than a big loss, you’ll want to take your time and learn the ins and outs of online investing first. This guide should help get...As the world’s leading animal health company, Zoetis is driven by a singular purpose: to nurture our world and humankind by advancing care for animals. After 70+ years of innovating ways to predict, prevent, detect and treat animal illness, Zoetis continues to stand by those raising and caring for animals worldwide — from livestock farmers ... Nov 24, 2023 · Zoetis : Company profile, business summary, shareholders, managers, financial ratings, industry, sector and market information | Nyse: ZTS | Nyse

See the latest Zoetis Inc Class A stock price (ZTS:XNYS), related news, valuation, dividends and more to help you make your investing decisions.Nov 24, 2023 · Zoetis : Company profile, business summary, shareholders, managers, financial ratings, industry, sector and market information | Nyse: ZTS | Nyse Zoetis Inc. announced that on February 5, 2023, Zoetis terminated Glenn David, Executive Vice President and Group President, U.S. Operations, Global Diagnostics and BioDevices at the Company, for violating company policy by engaging in a consensual personal relationship and failing to disclose it to the Company. Mr.The estimated Net Worth of Willie M Reed is at least $3.36 million dollars as of 11 February 2023. Willie Reed owns over 1,626 units of Zoetis Inc stock worth over $1,618,120 and over the last 9 years he sold ZTS stock worth over $1,411,766. In addition, he makes $330,000 as Independent Director at Zoetis Inc.Lbp Am Sa cut its stake in Zoetis Inc. (NYSE:ZTS - Free Report) by 23.6% during the 2nd quarter, according to its most recent Form 13F filing with the Securities …Dec 1, 2023 · Grading Zoetis Inc Stock. Before you choose to buy, sell or hold Zoetis Inc stock, you’ll want to analyze how it has been graded. Stock evaluation requires access to huge amounts of data and the knowledge and time to sift through it all, making sense of financial ratios, reading income statements and analyzing recent stock movement. Dec 3, 2023 · Get Zoetis Inc (ZTS.N) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investments. ... Zoetis Inc. is an animal health company. The Company ...

Analyzing ZTS Stock Performance. On Wednesday, Zoetis Inc [NYSE: ZTS] rose 0.35% to $179.35. The stock’s lowest price that day was $178.775, but it reached a high of $180.97 in the same session. During the last five days, there has been a surge of approximately 2.71%. Over the course of the year, Zoetis Inc shares have jumped approximately 22 ...

At Zoetis, we promise to treat your data with respect and will not share your information with any third party. You can unsubscribe to any of the investor alerts you are subscribed to by visiting the ‘unsubscribe’ section below. If you experience any issues with this process, please contact us for further assistance.Stefan Weiskopf ZTS stock SEC Form 4 insiders trading. Stefan has made over 1 trades of the Zoetis Inc stock since 2013, according to the Form 4 filled with the SEC. Most recently Stefan bought 320 units of ZTS stock worth $9,965 on 31 January 2013.. The largest trade Stefan's ever made was buying 320 units of Zoetis Inc stock on …Zoetis Declares Fourth Quarter 2023 Dividend. PARSIPPANY, N.J., October 12, 2023--The Board of Directors of Zoetis Inc. (NYSE:ZTS) has declared a dividend of $0.375 per share for the fourth ...Feb 15, 2023 · Zoetis shares rose 5.4% on Tuesday after Q4 2022 results showed its growth back on track. The P/E is now back to 35x. See why ZTS stock is a buy. Zoetis. Zoetis Inc. (/zō-EH-tis/ [4]) is an American drug company, the world's largest producer of medicine and vaccinations for pets and livestock. [5] [4] [6] The company was a subsidiary of Pfizer, [7] the world's largest drug maker, but with Pfizer's spinoff of its 83% interest in the firm it is now a completely independent company.Historical Stock Quote. Investment Calculator. Chart the performance of an investment in ZTS relative to market indices or to another stock over time. Amount ($)ZTS : 180.21 (+0.48%) 3 Pharma Stocks With Potential to Outperform Pfizer Inc. (PFE) in October stocknews.com - Thu Oct 5, 2:14PM CDT. Pfizer (PFE) is grappling with financial difficulties and declining performance. Yet, with growing pharmaceutical demand and industry advancements, robust pharma stocks Zoetis (ZTS), Horizon Therapeutics...Explore all Zoetis Animal Health products for companion animal and livestock, as well as our innovative diagnostic solutions. Learn more.In 2011, Zoetis Inc.’s revenues exceeded $4.2 billion and $4.34 billion in 2012. The animal health industry worldwide is an estimated US$22 billion dollar industry. IPO. Records show that Pfizer officially filled for registration of a Class A stock with the U.S. Securities and Exchange Commission on August 10, 2012.Get Zoetis Inc (ZTS.N) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investments. ... Zoetis Inc. is an animal health company. The Company ...

Get the latest Zoetis Inc. Class A (ZTS) stock price, news, buy or sell recommendation, and investing advice from Wall Street professionals.

Benefits. Revolution Plus is the most prescribed medicine for feline parasite protection1. Building on the legacy of Revolution® (selamectin), Revolution Plus is now the trusted choice. Revolution Plus is an all-in-one solution—one application a month defends against roundworms, hookworms, and heartworm disease plus has a unique dual action ...

See Best Monthly Dividend Stocks Model Portfolio for our top monthly income ideas. Growth Goal. ZTS. Target. Market- ...As the world’s leading animal health company, Zoetis is driven by a singular purpose: to nurture our world and humankind by advancing care for animals. After 70+ years of innovating ways to predict, prevent, detect and treat animal illness, Zoetis continues to stand by those raising and caring for animals worldwide — from livestock farmers to …Dec 3, 2023 · Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats ... Zoetis Inc. specializes in developing, manufacturing and marketing of animal health products. Net sales break down by activity as follows: - pets (64.4%): cats and dogs (94.9% of net sales) and horses (5.1%);Zoetis. Market Cap. Today's Change. Current Price. $180.21. Price as of November 24, 2023, 1:00 p.m. ET. You’re reading a free article with opinions that may differ from The Motley Fool’s ...Mar 1, 2023 · Headquartered in Parsippany, New Jersey, Zoetis Inc. (NYSE:ZTS) is an animal health medicines, vaccines, and diagnostic products manufacturer. On February 28, 2023, Zoetis Inc. (NYSE:ZTS) stock ... Nov 13, 2023 · Zoetis Inc. : Company profile, business summary, shareholders, managers, financial ratings, industry, sector and market information | Mexican Stock Exchange: ZTS ... Zoetis Inc. (4ZTS.BIT) : Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock Zoetis Inc. | Borsa Italiana: 4ZTS | Borsa Italiana

Prior to her executive leadership at Zoetis, Ms. Driscoll served in roles of increasing responsibility at Procter & Gamble from 1994 to 2016. She established and led the company’s global business development group in Geneva, Switzerland, during her tenure as Executive Global Head for Europe, Corporate Global Business Development …Sep 30, 2022 · PARSIPPANY, N.J. & RUTHERFORD, New South Wales, Australia--(BUSINESS WIRE)-- Zoetis Inc. (NYSE: ZTS) today announced it has completed the acquisition of Jurox, a privately held animal health company that develops, manufactures and markets a wide range of veterinary medicines for treating livestock and companion animals. PARSIPPANY, N.J., May 25, 2023--Zoetis Inc. (NYSE:ZTS) is hosting an investor day at 9:00 a.m. ET today at the New York Stock Exchange, where the company will dive into its compelling growth ...Instagram:https://instagram. iwm stocktwitsmichael wigginsproperty investment groupsindependent financial planners Lbp Am Sa cut its stake in Zoetis Inc. (NYSE:ZTS - Free Report) by 23.6% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC).The firm owned 129,342 shares of the company's stock after selling 40,018 shares during the period. Lbp Am Sa's holdings in Zoetis were worth … 100 best penny stocksstock research tools What is Zoetis Inc (ZTS)'s stock price today? The current price of ZTS is $175.79. The 52 week high of ZTS is $194.99 and 52 week low is $140.76. When is next earnings date of Zoetis Inc (ZTS)? ZTS : 180.21 (+0.48%) 3 Pharma Stocks With Potential to Outperform Pfizer Inc. (PFE) in October stocknews.com - Thu Oct 5, 2:14PM CDT. Pfizer (PFE) is grappling with financial difficulties and declining performance. Yet, with growing pharmaceutical demand and industry advancements, robust pharma stocks Zoetis (ZTS), Horizon Therapeutics... best stocks on cash app Mar 1, 2023 · Headquartered in Parsippany, New Jersey, Zoetis Inc. (NYSE:ZTS) is an animal health medicines, vaccines, and diagnostic products manufacturer. On February 28, 2023, Zoetis Inc. (NYSE:ZTS) stock ... May 4, 2023 · Zoetis Announces First Quarter 2023 Results. May 4, 2023. Reports Revenue of $2.0 Billion, Growing 1%, and Net Income of $552 Million, or $1.19 per Diluted Share, Decreasing 7% and 6%, Respectively, on a Reported Basis for First Quarter 2023. Delivers 4% Operational Growth in Revenue and a 3% Operational Decline in Adjusted Net Income for First ...